-
Zverev holds off Shelton to win US Open title
-
Swedish left-wing cheers far-right decline amid tight election race
-
Torres fires PSG to first win of Ligue 1 season
-
Yamal double helps Barca beat Levante, Atletico triumph
-
Toulouse back on track after hammering Bordeaux
-
Sassuolo stun Juve, Lobotka eases pressure on Allegri with Napoli winner
-
Referee body admits 'error' for Haaland goal in Manchester derby
-
Bills beat Texans and Ravens roll Colts in NFL openers
-
Sweden's election too close to call as far right loses ground
-
US fight off spirited France to win 12th World Cup
-
Is it possible to slow down the development of AI?
-
Drivers give cool reception to new Madring circuit
-
Jefferson-Wooden bags searing sprint double, Dos Santos on fire
-
Maresca makes flawless Man City start to leave Man Utd trailing
-
'Practical Magic 2' breaks Spidey spell over N. American box office
-
Dozens arrested in major anti-LGBTQ raids in Turkey
-
Comedian Chris Rock returns to directing with Hollywood drama 'Misty Green'
-
Leftwing opposition seen leading Sweden election, far-right losing ground
-
Spaniard Mas claims 'special' home Vuelta a Espana triumph
-
Senegal goalkeeper Mendy retires from international football
-
Jefferson-Wooden, Bednarek claim classy Ultimate sprint doubles
-
Carrick 'worried' by decision to award Man City winner
-
Britain's Kerr wins men's Ultimate 1,500m
-
Lobotka eases pressure on Allegri with Napoli winner
-
Luckless Norris wants change in safety car rules
-
Trump watches as Lowry wins Irish Open in record-breaking style
-
Spaniard Enric Mas wins home Vuelta a Espana
-
Poland, Ukraine slam Russian strikes near border as 'escalation'
-
Mercedes boss Wolff says long future for 'cucumber cool' Antonelli
-
Haaland fires 10-man Man City to memorable win over Man Utd
-
Kane edges Bayern past Elversberg in Bundesliga
-
I miss the adrenaline, but it's not my moment - Bolt
-
Trump administration reluctant to slow AI, Democrats see urgent need
-
Championship leader Antonelli to 'keep pushing' for title
-
Five-star Leipzig return to form with Hamburg thumping
-
Yamal double helps Barca edge Levante thriller
-
Spain beat Germany to claim women's World Cup bronze
-
دراسة على مستفيدي ميديكيد ترصد فجوة في العمر المتوقع للمصابين بالتوحد
-
أمودي يقترح رقابة مستقلة وتنسيقاً دولياً لضبط تطوير الذكاء الاصطناعي
-
Brighton run rampant against 10-man Coventry
-
Antonelli profits from safety car pause to win Spanish GP
-
Late Mbappe goal sends Lille top of Ligue 1
-
Trump chastises Zelensky over Russian refinery strikes during Ireland visit
-
Five-star Brighton crush 10-man Coventry
-
World championship leader Antonelli wins Spanish GP
-
Team Europe beat United States to reclaim Solheim Cup
-
Resurgent Marquez powers to San Marino win to take MotoGP lead
-
US House Speaker warns curbing AI too sharply could leave China ahead
-
Vuelta finale neutralised after rider safety concerns
-
張國榮70歲誕辰音樂會西九舉行 唐鶴德錄音致意
Conflicting US rulings leave fate of abortion pill in doubt
Conflicting rulings by two federal judges have left the future of abortion pills in the United States deeply uncertain, likely placing the divisive issue squarely in the lap of the Supreme Court.
A ruling Friday by federal judge Matthew Kacsmaryk in Texas banned the widely used drug mifepristone (RU 486) nationwide, boosting conservatives' efforts to further restrict abortion rights after the Supreme Court last year allowed states to prohibit them.
The unprecedented rejection of a drug approved in 2000 by the US Food and Drug Administration (FDA) -- and found safe by scientific consensus -- sparked outrage on the political left.
Kacsmaryk, in his ruling, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
His ruling brought an immediate vow from the Biden administration and the drug's maker to appeal the matter in federal court.
Attorney General Merrick Garland said the Justice Department would ask the appeals court to stay the ban by Kacsmaryk, an ultraconservative Donald Trump appointee, until the case is finally resolved.
If the Texas ruling holds, it would complicate matters not just in the states now banning or sharply limiting abortions, but also in those where the procedure remains legal.
- Widely used -
Mifepristone has been used as part of a two-drug regimen by 5.6 million women since 2000.
But adding to the uncertainty and increasing the odds the matter ends up before the Supreme Court was a contradictory ruling from a Washington state judge that came just hours after Kacsmaryk's.
District Judge Thomas Rice, a Barack Obama appointee, ruled in a separate case -- brought by several states where abortion is legal -- that mifepristone is "safe and legal" and that the FDA must preserve access to it in more than a dozen states.
For now the drug remains legal, Alexis McGill Johnson, the head of Planned Parenthood, one of the largest pro-abortion groups in the country, said Friday.
Several abortion clinics also said Friday that they would continue using mifepristone until ordered not to by the FDA, US media reported.
Kacsmaryk paused the effect of his ruling for a week, allowing time for the administration and drugmaker Danco Laboratories to file before the US Fifth Circuit Court of Appeals in Louisiana, which hears cases from Texas.
The Justice Department is still reviewing Rice's ruling, Garland said in a statement.
- 'Remains safe' -
Given the sharply conflicting court rulings, the Justice Department might opt to take the case directly to the Supreme Court and not wait for the Fifth Circuit to act.
The high court could decide to take up the case on an emergency basis, which would require making room in an already crowded agenda at the end of the current term.
In that case, the court -- with six conservative justices outnumbering the three liberals -- could hear the case within days, or weeks, but sometime before the current session ends on June 30.
Chief Justice John Roberts, a conservative, is deeply protective of the image of the institution, and he might be expected to vote with the three liberals in favor of mifepristone. The additional vote of one other conservative could provide a majority for the drug.
The court's ruling last June to overturn the longstanding Roe v. Wade decision protecting abortion rights shifted considerable attention to medication abortions.
Most of them involve mifepristone in a two-drug regimen. A patient first takes a mifepristone pill to end the pregnancy, then a day later takes the drug misoprostol to induce contractions that expel the embryo or fetus.
Misoprostol can be used on its own to cause abortions, but the two-step procedure is considered more effective and can be more painful.
More than half of abortions in the US are done with medication.
Kacsmaryk, in his ruling, said the two-drug regimen had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective.
Michigan Governor Gretchen Whitmer, a Democrat, tweeted:
"Despite this ruling, I want to be clear: abortion, including medication abortion, remains safe and legal in the state of Michigan."
Women's March, which has been organizing organizing major women's rights demonstrations in recent years, called for a nationwide rally defending abortion rights for April 15.
W.Mansour--SF-PST